86 results
Page 2 of 5
8-K
EX-99.1
jf4wlsb3dw
30 Jun 22
Regulation FD Disclosure
1:28pm
8-K
EX-99.1
o5chuh se3juair8rewf
10 May 22
AbCellera Reports Q1 2022 Business Results
4:17pm
8-K
EX-99.2
6d4mw hz9xc07h
10 May 22
AbCellera Reports Q1 2022 Business Results
4:17pm
S-3ASR
8guln7i2ms9a8
25 Feb 22
Automatic shelf registration
4:51pm
POS AM
2lvuu0b 16fva9ip5v
25 Feb 22
Prospectus update (post-effective amendment)
3:54pm
S-8
EX-99.4
39m8g3rhq2dm glk0x8
25 Feb 22
Registration of securities for employees
3:49pm
8-K
EX-99.1
rpoia83r4kc25
24 Feb 22
AbCellera Reports Full Year 2021 Business Results
5:02pm
424B3
1bzr3edg
15 Feb 22
Prospectus supplement
5:33pm
8-K
EX-99.1
tzu2d
15 Feb 22
AbCellera-Discovered Antibody, Bebtelovimab, Receives U.S. FDA Emergency Use Authorization for the Treatment of Mild-to-Moderate COVID-19
5:18pm
424B3
ddfkaz23xn98wlnestj
7 Dec 21
Prospectus supplement
4:05pm
8-K
EX-99.1
vfb o2z5hi
7 Dec 21
AbCellera Announces Changes to Its Board of Directors
4:00pm
424B3
9uv65s ski6
7 Dec 21
Prospectus supplement
12:00am
8-K
EX-99.1
pq0hhn en54d9x7
3 Dec 21
AbCellera Announces the Appointment of Neil Aubuchon as Chief Commercial Officer
1:38pm
424B3
hzurqzn n5
12 Nov 21
Prospectus supplement
6:11am
8-K
EX-99.2
lx433jjwa
9 Nov 21
AbCellera Reports Q3 2021 Business Results
5:00pm
8-K
EX-99.1
8l1onoqlvm165mlu
9 Nov 21
AbCellera Reports Q3 2021 Business Results
5:00pm
424B3
0s3ul7wr76vk3eyx
4 Nov 21
Prospectus supplement
4:47pm